Showing 61 - 80 results of 102 for search '"Gateshead"', query time: 0.19s Refine Results
  1. 61
  2. 62

    Social pedagogy, music making and adopted children by Ryan Humphrey

    Published 2020-03-01
    “…A case study strategy is used to examine the Loud and Clear adoption family learning project at Sage Gateshead, through which a multi-methodological approach was used, including interviews and participatory action research to gather participants’ and facilitators’ narratives of the impacts the sessions and approaches were having. …”
    Get full text
    Article
  3. 63
  4. 64
  5. 65

    Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature by White C, Scott RJ, Paul C, Ziolkowski A, Mossman D, Ackland S

    Published 2021-12-01
    “…Cassandra White,1,2 Rodney J Scott,1– 3 Christine Paul,1,2 Andrew Ziolkowski,3 David Mossman,3 Stephen Ackland1,2,4 1University of Newcastle, Newcastle, NSW, Australia; 2Hunter Cancer Research Alliance, Hunter Medical Research Institute, Newcastle, NSW, Australia; 3Division of Molecular Medicine, Pathology North John Hunter Hospital, Newcastle, NSW, Australia; 4Hunter Cancer Centre, Lake Macquarie Private Hospital, Gateshead, NSW, AustraliaCorrespondence: Cassandra WhiteHunter Medical Research Institute, Lot 1, Kookaburra Circuit, New Lambton Heights, NSW 2305, AustraliaTel +61 2 4042 0000Email cassandra.white10@uon.edu.auAbstract: Pharmacogenomic screening can identify patients with gene variants that predispose them to the development of severe toxicity from fluoropyrimidine (FP) chemotherapy. …”
    Get full text
    Article
  6. 66
  7. 67
  8. 68

    Iron Replacement Therapy with Oral Ferric Maltol: Review of the Evidence and Expert Opinion by Carsten Schmidt, Stephen Allen, Nelson Kopyt, Pablo Pergola

    Published 2021-09-01
    “…Writing support was provided by Shield Therapeutics (Gateshead, UK).…”
    Get full text
    Article
  9. 69
  10. 70
  11. 71
  12. 72

    A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial) by Ballard, C, Lana, M, Theodoulou, M, Douglas, S, McShane, R, Jacoby, R, Kossakowski, K, Yu, L, Juszczak, E

    Published 2008
    “…Setting: Oxfordshire, Newcastle and Gateshead, London and Edinburgh, United Kingdom. Participants: Patients currently prescribed the neuroleptics thioridazine, chlorpromazine, haloperidol trifluoperazine or risperidone for behavioural or psychiatric disturbance in dementia for at least 3 mo. …”
    Journal article
  13. 73
  14. 74
  15. 75

    A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). by Ballard, C, Lana, M, Theodoulou, M, Douglas, S, Mcshane, R, Jacoby, R, Kossakowski, K, Yu, L, Juszczak, E

    Published 2008
    “…SETTING: Oxfordshire, Newcastle and Gateshead, London and Edinburgh, United Kingdom. PARTICIPANTS: Patients currently prescribed the neuroleptics thioridazine, chlorpromazine, haloperidol trifluoperazine or risperidone for behavioural or psychiatric disturbance in dementia for at least 3 mo. …”
    Journal article
  16. 76

    A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial) by Ballard, C, Lana, M, Theodoulou, M, Douglas, S, McShane, R, Jacoby, R, Kossakowski, K, Yu, L, Juszczak, E

    Published 2008
    “…Setting: Oxfordshire, Newcastle and Gateshead, London and Edinburgh, United Kingdom. Participants: Patients currently prescribed the neuroleptics thioridazine, chlorpromazine, haloperidol trifluoperazine or risperidone for behavioural or psychiatric disturbance in dementia for at least 3 mo. …”
    Journal article
  17. 77
  18. 78
  19. 79
  20. 80

    A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). by Clive Ballard, Marisa Margallo Lana, Megan Theodoulou, Simon Douglas, Rupert McShane, Robin Jacoby, Katja Kossakowski, Ly-Mee Yu, Edmund Juszczak, Investigators DART AD

    Published 2008-04-01
    “…<h4>Setting</h4>Oxfordshire, Newcastle and Gateshead, London and Edinburgh, United Kingdom.<h4>Participants</h4>Patients currently prescribed the neuroleptics thioridazine, chlorpromazine, haloperidol trifluoperazine or risperidone for behavioural or psychiatric disturbance in dementia for at least 3 mo.…”
    Get full text
    Article